Stephen M. Ansell

Scientific Advisory Board

Stephen M. Ansell, M.D., Ph.D.

Professor of Medicine, Mayo Clinic. Rochester, MN Chair, Lymphoma Group, Division of Hematology.

First patient dosed with NILK-2301 in Phase I clinical trial

First-in-human trial of a CEACAM5xCD3 bispecific κλ body for solid cancer


Read more

LinkedIn